Advancing our knowledge of the role of PI3K(p110α) gene in the symptoms, pathophysiology, AF-associated risk factors, and in the incidence of AF will help to provide new preventive and treatment measures and reduce the public health burden of AF. This evidence concerns the gene PIK3CD and atrial fibrillation.